Literature DB >> 9548442

Transgenic mouse expressing a full-length hepatitis C virus cDNA.

J Matsuda1, M Suzuki, C Nozaki, N Shinya, K Tashiro, K Mizuno, Y Uchinuno, K Yamamura.   

Abstract

Hepatitis C virus (HCV), a major causative agent of post transfusion non-A, non-B hepatitis (NANBH), can only infect humans and chimpanzees. We produced nine transgenic mouse lines carrying a full-length HCV cDNA with the human serum amyloid P component (hSAP) promoter that can direct liver-specific expression. In one of these lines HCV mRNA and HCV core protein were detected in the liver of the transgenic mouse, although the levels of expression were very low. In addition, HCV-related antibody was detected in the serum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548442      PMCID: PMC5921765          DOI: 10.1111/j.1349-7006.1998.tb00543.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  48 in total

1.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.

Authors:  H Takashima; K Araki; J Miyazaki; K Yamamura; M Kimoto
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

4.  A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.

Authors:  F V Chisari; C A Pinkert; D R Milich; P Filippi; A McLachlan; R D Palmiter; R L Brinster
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

5.  Introduction of human gamma 1 immunoglobulin genes into fertilized mouse eggs.

Authors:  K Yamamura; H Kikutani; N Takahashi; T Taga; S Akira; K Kawai; K Fukuchi; Y Kumahara; T Honjo; T Kishimoto
Journal:  J Biochem       Date:  1984-08       Impact factor: 3.387

6.  In vivo transfection of hepatitis C virus complementary DNA into rodent liver by asialoglycoprotein receptor mediated gene delivery.

Authors:  M Yamamoto; N Hayashi; Y Miyamoto; T Takehara; E Mita; M Seki; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

7.  Developmental and liver-specific expression directed by the serum amyloid P component promoter in transgenic mice.

Authors:  X Zhao; K Araki; J Miyazaki; K Yamamura
Journal:  J Biochem       Date:  1992-06       Impact factor: 3.387

8.  Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.

Authors:  A Zibert; E Schreier; M Roggendorf
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

9.  Expression and identification of hepatitis C virus polyprotein cleavage products.

Authors:  A Grakoui; C Wychowski; C Lin; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Correlation of tissue-specific methylation with gene inactivity in hepatitis B virus transgenic mice.

Authors:  K Araki; K Akagi; J Miyazaki; K Matsubara; K Yamamura
Journal:  Jpn J Cancer Res       Date:  1990-12
View more
  4 in total

1.  Generation of the regulatory protein rtTA transgenic mice.

Authors:  Kang Xu; Xin-Yan Deng; Ying Yue; Zhong-Min Guo; Bing Huang; Xun Hong; Dong Xiao; Xi-Gu Chen
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

2.  Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.

Authors:  N Butkiewicz; N Yao; W Zhong; J Wright-Minogue; P Ingravallo; R Zhang; J Durkin; D N Standring; B M Baroudy; D V Sangar; S M Lemon; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 3.  Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies.

Authors:  Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

4.  Reduced body weight and increased energy expenditure in transgenic mice over-expressing soluble leptin receptor.

Authors:  Phing-How Lou; Guoqing Yang; Lu Huang; Yunxia Cui; Tiffany Pourbahrami; George K Radda; Cai Li; Weiping Han
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.